Patent 7860545 was granted and assigned to Dexcom on December, 2010 by the United States Patent and Trademark Office.
An implantable analyte-measuring device including a membrane adapted to promote vascularization and/or interfere with barrier cell layer formation. The membrane includes any combination of materials, architecture, and bioactive agents that facilitate analyte transport to provide long-term in vivo performance of the implantable analyte-measuring device.